Since 2000 focusing on alzheimers disease. The burden of the disease, a state of the research and the challenges faced. Going back many years we have heard predictions from experts about the farreaching consequences this disease will have on the quality of life for American Families and the burden that will place on our economy in the years ahead. Last april and a major study predicted that these consequences will be far greater than previously imagined. We will hear from the author of that study today on the next panel. Reviously imagined. Well hear from the author of that study today on the next panel. I wont steal his thunder, but i note this study commanded the attention of the nati, there are few americans whose life has not been tested in some way by alzheimers disease life hasnt been touched in some way by alzheimers disease. Whether through a Family Member or a friend. Its the most common form of dementia among Older Americans and its risk increases with increasing age. For tho
Policy. Or definitively saying what diseases money has to go to. Instead, we allow the peerreview process to support the most promising science. However, we were able to provide 131 million increase for the National Institute on ageing in the recent fiscal year 2014 omnibus. Again, with the expectation that promising science in alzheimers disease will be supported. We have a distinguished panel of experts here today, scientists, economists, patients, family members. We also have quite an audience. Let me welcome representatives of the Alzheimers Association. Some of you came a long way to be here today. We thank you for your tireless work to educate members of congress and the press about the need to do more to help you and your loved ones. Also in the audience are students, i am told, from the university of virginia. These young people are spending a day here learning about budget and appropriations, and we welcome all of you here also. On our first panel, of course, well hear from dr
Great work. Lets keep pushing. Theres more to do. As secretary sebelius said, we are starting to see some change. We are nowhere near the end of this road, but with every little bit that we do, we make a huge difference. Congratulations once again and keep up the great work. Thank you so much. [applause] [captioning performed by national captioning institute] [captions Copyright National cable satellite corp. 2014] all we are told there are sorts of citizens that occur. Sid isnt that occur. Rosa parks who was just so tired that she refused to get up from the bus and sparked the bus whoott and a young preacher the president referred to during one. He leads the africanamericans from nutrition. He could do this stuff. Then barack could fly. They sound good. They really simplify a much more complicated history. So manyy involves africanamericans who proactively dismantled racial segregation including rosa parks. Refuse to give this up. He specializes in the sub field of africana and what h
Encouraging minority participation in Clinical Trials is if the researchers themselves represent the diversity of our country. You can see that over and over again. This is a strong reason why we need to focus on improving and expanding our own work force. We have a number of new programs that are quite bold. This is a high personal priority for me, to try to see if we could do a better job of recruiting and retaining and mentoring it and supporting individuals from underrepresented groups in order to populate those Clinical Trial work forces with people who represent our country and would therefore be perhaps more welcoming to the groups that tentatively now are unsure if they want to join up or not. Dr. Hodes can tell you what were already doing in terms of alzheimers trials. All of our centers are engaged in that. We are indeed making great efforts to correct what you point out, an underrepresentation of minorities in clinical studies. All the Alzheimers Disease Research centers hav
Its based on something referred to as a fixed Market Basket, sort of like look at all the stuff people are buying at a point in time and how much to those prices go up. Would avoid two things you bought come you bought equal amounts, one of than doubled in price and the other one stayed the same, if one doubled and the other state the same, you would say, you at 50 increase in prices. So thats kind of what the fixed Market Basket approach would say. It tells you much the prices go up on the stuff that you have bought and that youve considered buying. Nothing is added in the cpi by the way for new things that come on the market. Some of us are old enough to remember vcrs coming around. Everyone here probably remembers when dvd players came around. Lots of other things like that. When they come into the cpi, they dont boost the level of cpi. Its just a rate of change and the prices of things that are already out there. An interesting thing about the nature of new things that come in, new